References

1. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006; 29(3):375-380.

2. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med 2005; 142(3): 187-197.

3. Sundaram S, Bridgman SA, Lim J, Lasserson TJ. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev 2005; 1:1-66.

4. Shamsuzzaman ASM, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003; 290(14):1906-1914.

5. Flemons WW. Obstructive sleep apnea. N Engl J Med 2002; 347(7):498-504.

6. Grunstein RR, Hedner J, Grote L. Treatment options for sleep apnea. Drugs 2001; 61(2):237-251.

7. Farney RJ, Lugo A, Jensen RL, et al. Simultaneous use of antidepressant and antihypertensive medications increases likelihood of diagnosis of obstructive sleep apnea syndrome. Chest 2004; 125:1279-1285.

8. Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep 2005; 28(4):464-471.

9. Pack AI, Black JE, Schwartz JRL, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001; 164:1675-1681.

10. Keating GM, Raffin MJ. Modafinil: a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. CNS Drugs 2005; 19(9):785-803.

11. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348(13):1233-1241.

12. Robertson P Jr, Hellriegel ET, Arora S, et al. Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers. Clin Pharmcol Ther 2002; 71(1):46-56.

13. Dequardo JR. Modafinil-associated clozapine toxicity. Am J Psychiatry 2002; 7:1243.

14. Robinson RW, Zwillich CW. Medications, sleep, and breathing. In: Kryger MH, Roth T, Dement WC, eds. Principles of Sleep Medicine. 3rd ed, ch. 69. Philadelphia, PA: W.B. Saunders Co, 2000.

15. Sanders M. Medical therapy for obstructive sleep apnea-hypopnea syndrome. In: Kryger MH, Roth T, Dement WC, eds. Principles of Sleep Medicine. 3rd ed, Chapter 75. Philadelphia, PA: W.B. Saunders Co, 2000:879-892.

16. Inoue Y, Takata K, Sakamoto I, et al. Clinical efficacy and indication of acetazolamide treatment on sleep apnea syndrome. Psychiatry Clin Neurosci 1999; 53(2):321-322.

17. Kraiczi H, Hedner J, Dahlof P, et al. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999; 22(1):61-67.

18. Berry RB, Yamaura EM, Gill K, Reist C. Acute effects of paroxetine on geniogulossus activity in obstructive sleep apnea. Sleep 1999; 22(8):1087-1092.

19. Avidan AV. Sleep in the geriatric patient population. Semin Neurol 2005; 25(1):52-63.

20. Young T, Finn L, Austin D, et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003; 167:1181-1185.

21. Tun Ye, Hida W, Okabe S, et al. Can nasal continuous positive airway pressure decrease clinic blood pressure in patients with obstructive sleep apnea? Tohoku J Exp Med 2003; 201:181-190.

22. Bartel PR, Loock M, Becker P, et al. Short-term antihypertensive medication does not exacerbate sleep-disordered breathing in newly diagnosed hypertensive patients. Am J Hypertens 1997; 10:640-645.

23. Borgel J, Sanner BM, Keskin F, et al. Obstructive sleep apnea and blood pressure. Am J Hypertens 2004; 17:1081-1087.

24. Albarrak M, Banno K, Sabbagh AA, et al. Utilization of healthcare resources in OSA syndrome: a 5-year follow-up study in men using CPAP. Sleep 2005; 28(10):1306-1311.

25. Nozaki-Taguchi N, Isono S, Nishino T, et al. Upper airway obstruction during mida-zolam sedation: modification by nasal CPAP. Can J Anaesth 1995; 42(8):685-690.

26. Jain SS, Dhand R. Perioperative treatment of patients with obstructive sleep apnea. Curr Opin Pulm Med 2004; 10:482-488.

27. Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest 2005; 128:1348-1356.

28. White D. Central sleep apnea. In: Kryger MH, Roth T, Dement WC, eds. Principles of Sleep Medicine. 3rd ed, Chapter 71. Philadelphia, PA: WB Saunders Co, 2000:827-839.

29. Top 200 Prescription Drugs of 2005. Pharmacy Times, May 2006:26-30. www.pharmacy-times.com.

30. Camacho ME, Morin CM. The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea. Sleep 1995; 18(8):644-645.

31. Benca R. Diagnosis and treatment of chronic insomnia: a review. Psychiatric Services. 2005; 56:332-343.

32. Lunesta, Package Insert. www.lunesta.com. (accessed 2-11-05).

33. Ambien CR Package Insert. www.ambiencr.com (accessed 1-12-06).

34. Terzano MG, Rossi M, Palomba V, et al. New drugs for insomnia: comparative tolera-bility of zopiclone, Zolpidem and zaleplon. Drug Safety 2003; 26(4):261-282.

35. Girault C, Muir JF, Mihaltan F, et al. Effects of repeated administration of Zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance inpatients with COPD. Chest 1996; 110(5):1203-1211.

36. Bassiri AG, Guilleminault C. Clinical features and evaluation of OSA-HS. In: Kryger MH, Roth T, Dement WC, eds. Principles of Sleep Medicine. 3rd ed, Chapter 74. Philadelphia, PA: W.B. Saunders, 2000.

Sleep Like A PRO

Sleep Like A PRO

Learning About How To Sleep Like A PRO Can Have Amazing Benefits For Your Life And Success. Learn About Mastering Your Sleep Patterns For Maximum Productivity To Create Amazing Results!

Get My Free Ebook


Post a comment